Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aromatase Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01797120
What this trial is testing

Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI

Who this might be right for
Metastatic Breast Cancer
PrECOG, LLC. 131
Testing effectiveness (Phase 2)Study completedNCT00451555
What this trial is testing

Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 156
Not applicableLooking for participantsNCT04476485
What this trial is testing

Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

Who this might be right for
Breast Cancer
Shengjing Hospital 1,000
Large-scale testing (Phase 3)Looking for participantsNCT04111978
What this trial is testing

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

Who this might be right for
Ovarian Neoplasm EpithelialFallopian Tube NeoplasmsPeritoneal Neoplasms+3 more
Swiss GO Trial Group 540
Not applicableStudy completedNCT02753985
What this trial is testing

Adherence to Aromatase Inhibitors: The Role of Partners

Who this might be right for
Breast Cancer Survivors
Abramson Cancer Center at Penn Medicine 40
Not applicableStudy completedNCT07072013
What this trial is testing

An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,937
Large-scale testing (Phase 3)Study completedNCT00022672
What this trial is testing

Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 208
Not applicableNot Yet RecruitingNCT07833501
What this trial is testing

Estradiol Levels According to Body Mass Index in Premenopausal Patients With Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast Cancer
D'Or Institute for Research and Education 172
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07571928
What this trial is testing

A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

Who this might be right for
Infertility Due to AzoospermiaInfertility, Male
Martin Blomberg Jensen 15
Testing effectiveness (Phase 2)Study completedNCT01491737
What this trial is testing

Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 258
Post-approval studies (Phase 4)Not Yet RecruitingNCT06985186
What this trial is testing

Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial

Who this might be right for
Adenomyosis of UterusInfertility Assisted Reproductive Technology
University of Palermo 162
Large-scale testing (Phase 3)Study completedNCT00301457
What this trial is testing

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

Who this might be right for
Breast Cancer
Maastricht University Medical Center 1,914
Not applicableStudy completedNCT01016665
What this trial is testing

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

Who this might be right for
Breast Cancer
Federal University of São Paulo 71
Not applicableTemporarily pausedNCT01137136
What this trial is testing

Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea

Who this might be right for
PolymorphismCYP19Aromatase Inhibitor
Samsung Medical Center 300
Not applicableLooking for participantsNCT06650423
What this trial is testing

Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

Who this might be right for
Early Breast CancerHormone Receptor Positive TumorHER2-negative Breast Cancer
Institute of Oncology Ljubljana 319
Post-approval studies (Phase 4)Study completedNCT04705883
What this trial is testing

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

Who this might be right for
Vulvar AtrophyBreast CancerGenitourinary Syndrome of Menopause
Hospital Clinic of Barcelona 10
Not applicableStudy completedNCT00997373
What this trial is testing

Letrozole as a Treatment of Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
University of California, Davis 43
Not applicableStudy completedNCT00111241
What this trial is testing

Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

Who this might be right for
Arthralgia
Monash University 115
Post-approval studies (Phase 4)Study completedNCT05631795
What this trial is testing

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 40
Not applicableUnknownNCT05264649
What this trial is testing

Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer

Who this might be right for
Arthralgia
Show Chwan Memorial Hospital 72
Next Page